194 related articles for article (PubMed ID: 29412186)
1. Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis.
Zhang N; Li C; Zhou D; Ding C; Jin Y; Tian Q; Meng X; Pu K; Zhu Y
Acta Biomater; 2018 Apr; 70():227-236. PubMed ID: 29412186
[TBL] [Abstract][Full Text] [Related]
2. cRGD Urokinase Liposomes for Thrombolysis in Rat Model of Acute Pulmonary Microthromboembolism.
Liang C; Huang T; Zhang X; Rao H; Jin Z; Pan X; Li J; Mo Y; Cai Y; Wu J
Drug Des Devel Ther; 2022; 16():801-816. PubMed ID: 35370400
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis based on magnetically-controlled surface-functionalized Fe
Chang M; Lin YH; Gabayno JL; Li Q; Liu X
Bioengineered; 2017 Jan; 8(1):29-35. PubMed ID: 27689864
[TBL] [Abstract][Full Text] [Related]
4. Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for
Li J; Zhang X; Mo Y; Huang T; Rao H; Tan Z; Huang L; Zeng D; Jiang C; Zhong Y; Cai Y; Liang B; Wu J
Front Bioeng Biotechnol; 2022; 10():1038829. PubMed ID: 36324896
[No Abstract] [Full Text] [Related]
5. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
[TBL] [Abstract][Full Text] [Related]
6. Cyclic RGD functionalized liposomes targeted to activated platelets for thrombosis dual-mode magnetic resonance imaging.
Ye S; Liu Y; Lu Y; Ji Y; Mei L; Yang M; Gong X; Gu Q; Li D; Yang F; Li CJ
J Mater Chem B; 2020 Jan; 8(3):447-453. PubMed ID: 31833530
[TBL] [Abstract][Full Text] [Related]
7. Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis.
Bi F; Zhang J; Su Y; Tang YC; Liu JN
Biomaterials; 2009 Oct; 30(28):5125-30. PubMed ID: 19560812
[TBL] [Abstract][Full Text] [Related]
8. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.
Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y
Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174
[TBL] [Abstract][Full Text] [Related]
9. Deep Penetration of Targeted Nanobubbles Enhanced Cavitation Effect on Thrombolytic Capacity.
Ma L; Wang Y; Zhang S; Qian X; Xue N; Jiang Z; Akakuru OU; Li J; Xu Y; Wu A
Bioconjug Chem; 2020 Feb; 31(2):369-374. PubMed ID: 31765569
[TBL] [Abstract][Full Text] [Related]
10. Combined Low-Frequency Ultrasound and Urokinase-Containing Microbubbles in Treatment of Femoral Artery Thrombosis in a Rabbit Model.
Zhu Y; Guan L; Mu Y
PLoS One; 2016; 11(12):e0168909. PubMed ID: 28033371
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of thrombus-targeted urokinase liposomes and its thrombolytic effect in model rats].
Wang XT; Li S; Zhang XB; Hou XP
Yao Xue Xue Bao; 2003 Mar; 38(3):231-5. PubMed ID: 12830724
[TBL] [Abstract][Full Text] [Related]
12. Cyclic RGD functionalized PLGA nanoparticles loaded with noncovalent complex of indocyanine green with urokinase for synergistic thrombolysis.
Zhang S; Li J; Ren J; Xue Z; Qi X; Si Q
Front Bioeng Biotechnol; 2022; 10():945531. PubMed ID: 36032719
[TBL] [Abstract][Full Text] [Related]
13. In vitro thrombolytic efficacy of echogenic liposomes loaded with tissue plasminogen activator and octafluoropropane gas.
Shekhar H; Bader KB; Huang S; Peng T; Huang S; McPherson DD; Holland CK
Phys Med Biol; 2017 Jan; 62(2):517-538. PubMed ID: 28002053
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of thrombolysis in a porcine model of chronic deep venous thrombosis: an endovascular model.
Lin PH; Chen C; Surowiec SM; Conklin B; Bush RL; Lumsden AB
J Vasc Surg; 2001 Mar; 33(3):621-7. PubMed ID: 11241136
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy.
Huang Y; Gu B; Salles-Crawley II; Taylor KA; Yu L; Ren J; Liu X; Emerson M; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078604
[TBL] [Abstract][Full Text] [Related]
16. Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.
Bonnard T; Tennant Z; Niego B; Kanojia R; Alt K; Jagdale S; Law LS; Rigby S; Medcalf RL; Peter K; Hagemeyer CE
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159824
[TBL] [Abstract][Full Text] [Related]
17. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
[TBL] [Abstract][Full Text] [Related]
18. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
19. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
Absar S; Nahar K; Kwon YM; Ahsan F
Pharm Res; 2013 Jun; 30(6):1663-76. PubMed ID: 23468049
[TBL] [Abstract][Full Text] [Related]
20. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.
Wang X; Palasubramaniam J; Gkanatsas Y; Hohmann JD; Westein E; Kanojia R; Alt K; Huang D; Jia F; Ahrens I; Medcalf RL; Peter K; Hagemeyer CE
Circ Res; 2014 Mar; 114(7):1083-93. PubMed ID: 24508759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
